BEST UNLIMITED TURBO LONG CERTIFICATE - ROCHE GS Stock

Certificat

SV94S

DE000SQ8JBZ8

Real-time Euronext Paris 11:00:16 2024-05-02 EDT
0.074 EUR -74.57% Intraday chart for BEST UNLIMITED TURBO LONG CERTIFICATE - ROCHE GS
Current month-73.19%
1 month-90.19%

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Société Générale Société Générale
SV94S
ISINDE000SQ8JBZ8
Date issued 2023-02-01
Strike 214.4 CHF
Maturity Unlimited
Parity 20 : 1
Emission price 3.8
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.438
Lowest since issue 0.052

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
227.8 CHF
Average target price
279.4 CHF
Spread / Average Target
+22.65%
Consensus
  1. Stock Market
  2. Certificates
  3. SV94S Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW